Evidence map›Paper›PMID 33557061›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Third Generation Cephalosporin Resistant

Anat Shnaiderman-Torban, Dror Marchaim, Shiri Navon-Venezia, Ori Lubrani, Yossi Paitan, Haya Arielly, Amir Steinman

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Antimicrobial resistance and genetic diversity ofFrontiers in microbiology · 2023
    Article
  3. Article
  4. Article
  5. Occurrence and Antimicrobial Susceptibility Profiles ofAntibiotics (Basel, Switzerland) · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Anat Shnaiderman-TorbanKoret School of Veterinary Medicine (KSVM), The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7610001, Israel.
Dror MarchaimUnit of Infection Control, Shamir (Assaf Harofeh) Medical Center, Zerifin, Beer Yaakov 70300, Israel.
Shiri Navon-VeneziaDepartment of Molecular Biology, Faculty of Natural Science, Ariel University, Ariel 40700, Israel.ORCID 0000-0002-4916-110X
Ori LubraniKoret School of Veterinary Medicine (KSVM), The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7610001, Israel.
Yossi PaitanDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Haya AriellyDepartment of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
Amir SteinmanKoret School of Veterinary Medicine (KSVM), The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot 7610001, Israel.ORCID 0000-0003-0984-6822
Hebrew University of Jerusalem · ILTel Aviv University · ILAriel University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In human medicine, infections caused by third-generation cephalosporin-resistant

Indexed as

case–case–controlcephalosporinsequineextended-spectrum β-lactamaseresistance

Identifiers

PMID33557061
PMCPMC7913880
OpenAlexW3126947822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.